Clinical trials
Completed Hemophilia A trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
168 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 4 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 6 |
| 2006 | 7 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 10 |
| 2011 | 9 |
| 2012 | 10 |
| 2013 | 8 |
| 2014 | 12 |
| 2015 | 16 |
| 2016 | 9 |
| 2017 | 12 |
| 2018 | 19 |
| 2019 | 5 |
| 2020 | 7 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 168 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 24 |
| Baxalta now part of Shire | 22 |
| Bayer | 18 |
| Bioverativ Therapeutics Inc. | 6 |
| CSL Behring | 6 |
| Genzyme, a Sanofi Company | 6 |
| Hoffmann-La Roche | 6 |
| Octapharma | 6 |
| Pfizer | 6 |
| BioMarin Pharmaceutical | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemophilia A | 168 |
| Hemophilia B | 29 |
| Blood Coagulation Disorders | 12 |
| Hematologic Diseases | 12 |
| Coagulation Protein Disorders | 10 |
| Hemorrhagic Disorders | 10 |
| Blood Coagulation Disorders, Inherited | 9 |
| Genetic Diseases, Inborn | 9 |
| Hemostatic Disorders | 7 |
| Genetic Diseases, X-Linked | 5 |
Trials
Showing 1 to 25 of 168. Each trial links to its page on Pharma Observatory.
68 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.